Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney

Yuhki Koga; Akinobu Matsuzaki; Aiko Suminoe; Miho Hatano; Yusuke Saito; Yoshiaki Kinoshita; Tatsuro Tajiri; Tomoaki Taguchi; Kenichi Kohashi; Yoshinao Oda; Masazumi Tsuneyoshi; Toshiro Hara

doi:10.1002/pbc.21958

Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney

Yuhki Koga, Akinobu Matsuzaki, Aiko Suminoe, Miho Hatano, Yusuke Saito, Yoshiaki Kinoshita, Tatsuro Tajiri, Tomoaki Taguchi, Kenichi Kohashi, Yoshinao Oda, Masazumi Tsuneyoshi, Toshiro Hara

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

23 被引用数 (Scopus)

抄録

A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.

本文言語	英語
ページ（範囲）	888-890
ページ数	3
ジャーナル	Pediatric Blood and Cancer
巻	52
号	7
DOI	https://doi.org/10.1002/pbc.21958
出版ステータス	出版済み - 7月 1 2009

!!!All Science Journal Classification (ASJC) codes

小児科学、周産期医学および子どもの健康
血液学
腫瘍学

文献へのアクセス

10.1002/pbc.21958

他のファイルとリンク

フィンガープリント

「Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Koga, Y., Matsuzaki, A., Suminoe, A., Hatano, M., Saito, Y., Kinoshita, Y., Tajiri, T., Taguchi, T., Kohashi, K., Oda, Y., Tsuneyoshi, M., & Hara, T. (2009). Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney. Pediatric Blood and Cancer, 52(7), 888-890. https://doi.org/10.1002/pbc.21958

Koga, Y, Matsuzaki, A, Suminoe, A, Hatano, M, Saito, Y, Kinoshita, Y, Tajiri, T, Taguchi, T, Kohashi, K, Oda, Y, Tsuneyoshi, M & Hara, T 2009, 'Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney', Pediatric Blood and Cancer, vol. 52, no. 7, pp. 888-890. https://doi.org/10.1002/pbc.21958

@article{23458a54207c4e1bb6d796a517ac7103,

title = "Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney",

abstract = "A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.",

author = "Yuhki Koga and Akinobu Matsuzaki and Aiko Suminoe and Miho Hatano and Yusuke Saito and Yoshiaki Kinoshita and Tatsuro Tajiri and Tomoaki Taguchi and Kenichi Kohashi and Yoshinao Oda and Masazumi Tsuneyoshi and Toshiro Hara",

year = "2009",

month = jul,

day = "1",

doi = "10.1002/pbc.21958",

language = "English",

volume = "52",

pages = "888--890",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "7",

}

TY - JOUR

T1 - Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney

AU - Koga, Yuhki

AU - Matsuzaki, Akinobu

AU - Suminoe, Aiko

AU - Hatano, Miho

AU - Saito, Yusuke

AU - Kinoshita, Yoshiaki

AU - Tajiri, Tatsuro

AU - Taguchi, Tomoaki

AU - Kohashi, Kenichi

AU - Oda, Yoshinao

AU - Tsuneyoshi, Masazumi

AU - Hara, Toshiro

PY - 2009/7/1

Y1 - 2009/7/1

N2 - A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.

AB - A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.

UR - http://www.scopus.com/inward/record.url?scp=67650499564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650499564&partnerID=8YFLogxK

U2 - 10.1002/pbc.21958

DO - 10.1002/pbc.21958

M3 - Article

C2 - 19260106

AN - SCOPUS:67650499564

SN - 1545-5009

VL - 52

SP - 888

EP - 890

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 7

ER -